These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1731749)

  • 1. Expression of c-myc and c-fos in rat skeletal muscle. Evidence for increased levels of c-myc mRNA during hypertrophy.
    Whitelaw PF; Hesketh JE
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):143-7. PubMed ID: 1731749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased association of ribosomes with myofibrils during the skeletal-muscle hypertrophy induced either by the beta-adrenoceptor agonist clenbuterol or by tenotomy.
    Horne Z; Hesketh J
    Biochem J; 1990 Dec; 272(3):831-3. PubMed ID: 2268305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle.
    Babij P; Booth FW
    Am J Physiol; 1988 May; 254(5 Pt 1):C657-60. PubMed ID: 2834957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes.
    Petrou M; Wynne DG; Boheler KR; Yacoub MH
    Circulation; 1995 Nov; 92(9 Suppl):II483-9. PubMed ID: 7586459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue.
    Santalucía T; Camps M; Castelló A; Muñoz P; Nuel A; Testar X; Palacin M; Zorzano A
    Endocrinology; 1992 Feb; 130(2):837-46. PubMed ID: 1370797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle.
    Maltin CA; Delday MI; Hay SM; Smith FG; Lobley GE; Reeds PJ
    Biosci Rep; 1987 Feb; 7(2):143-9. PubMed ID: 2443196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the cyclo-oxygenase inhibitor, fenbufen, on clenbuterol-induced hypertrophy of cardiac and skeletal muscle of rats.
    Palmer RM; Delday MI; McMillan DN; Noble BS; Bain P; Maltin CA
    Br J Pharmacol; 1990 Dec; 101(4):835-8. PubMed ID: 1707704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clenbuterol increases the expression of myogenin but not myoD in immobilized rat muscles.
    Delday MI; Maltin CA
    Am J Physiol; 1997 May; 272(5 Pt 1):E941-4. PubMed ID: 9176197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the hypertrophic action of clenbuterol on denervated rat muscle is not propranolol-sensitive.
    Maltin CA; Hay SM; Delday MI; Reeds PJ; Palmer RM
    Br J Pharmacol; 1989 Apr; 96(4):817-22. PubMed ID: 2472845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of myosin heavy-chain gene expression during skeletal-muscle hypertrophy.
    Periasamy M; Gregory P; Martin BJ; Stirewalt WS
    Biochem J; 1989 Feb; 257(3):691-8. PubMed ID: 2539093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth.
    DeVol DL; Rotwein P; Sadow JL; Novakofski J; Bechtel PJ
    Am J Physiol; 1990 Jul; 259(1 Pt 1):E89-95. PubMed ID: 2372054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers.
    Wang JY; Johnson LR
    Am J Physiol; 1994 May; 266(5 Pt 1):G878-86. PubMed ID: 8203532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age effects on myosin subunit and biochemical alterations with skeletal muscle hypertrophy.
    Kandarian SC; Schulte LM; Esser KA
    J Appl Physiol (1985); 1992 May; 72(5):1934-9. PubMed ID: 1534798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satellite cells in innervated and denervated muscles treated with clenbuterol.
    Maltin CA; Delday MI
    Muscle Nerve; 1992 Aug; 15(8):919-25. PubMed ID: 1495507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some hormonal factors (hypophysectomy, castration and testosterone administration) modifying the course of "compensatory" muscle hypertrophy in the rat.
    Macková EV; Hník P
    Physiol Bohemoslov; 1976; 25(4):325-32. PubMed ID: 162621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.
    Akutsu S; Shimada A; Yamane A
    Br J Pharmacol; 2006 Feb; 147(4):412-21. PubMed ID: 16402040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β₂-adrenergic agonist.
    Abo T; Iida RH; Kaneko S; Suga T; Yamada H; Hamada Y; Yamane A
    Cell Biochem Funct; 2012 Dec; 30(8):671-6. PubMed ID: 22696074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-myc and c-fos protooncogenes in the anterior pituitary gland of the rat. Effect of estrogen.
    Szijan I; Parma DL; Engel NI
    Horm Metab Res; 1992 Apr; 24(4):154-7. PubMed ID: 1601388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and physiologic characteristics of skeletal muscle determine its response to clenbuterol treatment.
    Sundal S; Katoch SS; Sharma S
    Indian J Biochem Biophys; 2006 Jun; 43(3):160-6. PubMed ID: 16967905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.